Erez Vigodman

Teva Pharmaceutical Industries Ltd (ADR) (NYSE: TEVA), the troubled Israel-based generic and specialty medicines developer, confirmed with Bloomberg a plan to lower expenses and better manage its debt. A Bloomberg report cited Israeli-based news sources Calcalist, which initially reported Teva...

Teva Pharmaceutical Industries Ltd (ADR) (NYSE: TEVA) announced Monday after the bell that its president and CEO Erez Vigodman will step down, effective immediately. The company also said its chairman since January 2015 Yitzhak Peterburg will assume the role of president and CEO on an interim...

On Feb. 6, Teva Pharmaceutical Industries Ltd (ADR) (NYSE: TEVA) announced CEO Erez Vigodman was stepping down and chairman of the board Yitzhak Peterburg would take over as the interim CEO, while Sol Barer would take on the role of the chairman of the board. Bernstein’s Aaron (Ronny) Gal...

Bernstein said the departure of Siggi Olafsson is negative for Teva Pharmaceutical Industries Ltd (ADR) (NYSE: TEVA), as investors may fear the move is reflective of deeper malaise. ADRs of Teva were down 3.89 percent in Tuesday’s pre-market hours. Olafsson's Departure Teva announced that...

Here's a look at the top tickers trending on StockTwits.com. Teva Pharmaceutical: CEO hosts UK and Israeli leaders Teva Pharmaceuticals (NASDAQ: TEVA) announced a collaboration between Teva and the United Kingdom Government's National Health Service National Institute for Health Research (NIHR)...

Major indices saw plenty of red during the first trading session of 2014. There were no fundamental reasons for the Dow to suffer a triple digit point loss, along with the S&P 500 and Nasdaq indices ending the day lower. "People are taking profits and seeking bargains," according to Jim...